Clinical Trials Browser

Phase 1 × selicrelumab × Tumor-Agnostic × Clear all

NCT00607048 2017-03-27

Dose Finding Study Of CP-870,893, An Immune System Stimulating Antibody, In Combination With Paclitaxel And Carboplatin For Patients With Metastatic Solid Tumors

Phase 1 Completed

34 enrolled 18 charts

Neoplasms